These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30232086)

  • 1. Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo.
    Parvathaneni K; Scott DW
    Blood Adv; 2018 Sep; 2(18):2332-2340. PubMed ID: 30232086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells.
    Pohl AP; Venkatesha SH; Zhang AH; Scott DW
    Front Immunol; 2020; 11():693. PubMed ID: 32373126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells.
    Zhang AH; Yoon J; Kim YC; Scott DW
    J Immunol; 2018 Sep; 201(5):1434-1441. PubMed ID: 30021767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins.
    Lei TC; Scott DW
    Blood; 2005 Jun; 105(12):4865-70. PubMed ID: 15769892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
    Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM
    Front Immunol; 2020; 11():1293. PubMed ID: 32670285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
    Wang W; Merchlinsky M; Inman J; Golding B
    Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII.
    Yoon J; Schmidt A; Zhang AH; Königs C; Kim YC; Scott DW
    Blood; 2017 Jan; 129(2):238-245. PubMed ID: 28064157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro.
    Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A
    Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders.
    Hausl C; Ahmad RU; Schwarz HP; Muchitsch EM; Turecek PL; Dorner F; Reipert BM
    Blood; 2004 Jul; 104(1):115-22. PubMed ID: 15001466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of factor VIII-specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A.
    Brettschneider K; Schmidt A; Kahle J; Orlowski A; Stichel D; Schwabe D; Königs C
    J Thromb Haemost; 2018 Nov; 16(11):2223-2232. PubMed ID: 30152083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.
    Hausl C; Ahmad RU; Sasgary M; Doering CB; Lollar P; Richter G; Schwarz HP; Turecek PL; Reipert BM
    Blood; 2005 Nov; 106(10):3415-22. PubMed ID: 16091456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapies.
    Adair P; Su Y; Scott DW
    Discov Med; 2013 May; 15(84):275-82. PubMed ID: 23725600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
    Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.
    Zerra PE; Cox C; Baldwin WH; Patel SR; Arthur CM; Lollar P; Meeks SL; Stowell SR
    Blood; 2017 Dec; 130(23):2559-2568. PubMed ID: 28978569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q
    J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of FVIII in the Presence of Phosphatidyl Serine Reduces Generation of Memory B-Cells and Induces Regulatory T-Cell-Mediated Hyporesponsiveness in Hemophilia A Mice.
    Ramakrishnan R; Davidowitz A; Balu-Iyer SV
    J Pharm Sci; 2015 Aug; 104(8):2451-6. PubMed ID: 26038127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C
    Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.